Karl B Swedberg

机构：University of Gothenburg · ORCID：0000-0002-6358-2154

发表论文 721 篇 · 总被引 105040 次 · h-index 141

代表论文

• Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox (2023 · European Heart Journal · 被引 251)
• A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function (2021 · Kidney International · 被引 95)
• Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial (2025 · The Lancet · 被引 84)
• Angiotensin–neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure (2022 · European Journal of Heart Failure · 被引 53)
• Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure (2022 · JAMA Cardiology · 被引 49)
• Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials (2025 · The Lancet · 被引 46)